vs
アプターグループ（ATR）とCboe Global Markets（CBOE）の財務データ比較。上の社名をクリックして会社を切り替えられます
Cboe Global Marketsの直近四半期売上が大きい（$1.2B vs $962.7M、アプターグループの約1.3倍）。Cboe Global Marketsの純利益率が高く（26.0% vs 7.7%、差は18.3%）。アプターグループの前年同期比売上増加率が高い（13.5% vs 8.7%）。Cboe Global Marketsの直近四半期フリーキャッシュフローが多い（$332.1M vs $96.9M）。過去8四半期でCboe Global Marketsの売上複合成長率が高い（12.2% vs 2.6%）
アプターグループ（AptarGroup, Inc.）は米国に本社を置くグローバルな製造企業で、消費者向け分注包装製品と薬物送達デバイスの研究開発・生産を主力事業とし、世界18カ国に生産拠点を展開しています。
Cboe Global Markets, Inc.は米国シカゴに本社を置く金融取引所運営企業です。株式、オプション、先物、デジタル資産などの分野にわたる複数の取引所・取引場を所有・運営し、世界中の市場参加者に取引プラットフォームを提供しています。
ATR vs CBOE — 直接比較
売上が大きい
CBOE
1.3倍大きい
$962.7M
売上成長率が高い
ATR
+4.8%の差
8.7%
純利益率が高い
CBOE
純利益率が18.3%高い
7.7%
フリーキャッシュフローが多い
CBOE
FCF $235.2M多い
$96.9M
2年売上CAGRが高い
CBOE
2年複合成長率
2.6%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $962.7M | $1.2B |
| 純利益 | $74.3M | $313.5M |
| 粗利率 | — | 55.7% |
| 営業利益率 | 11.0% | 33.5% |
| 純利益率 | 7.7% | 26.0% |
| 売上前年比 | 13.5% | 8.7% |
| 純利益前年比 | -26.4% | 59.5% |
| EPS（希薄化後） | $1.13 | $2.97 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上ATRCBOE
| Q4 25 | $962.7M | $1.2B | ||
| Q3 25 | $961.1M | $1.1B | ||
| Q2 25 | $966.0M | $1.2B | ||
| Q1 25 | $887.3M | $1.2B | ||
| Q4 24 | $848.1M | $1.1B | ||
| Q3 24 | $909.3M | $1.1B | ||
| Q2 24 | $910.1M | $974.0M | ||
| Q1 24 | $915.4M | $957.2M |
純利益ATRCBOE
| Q4 25 | $74.3M | $313.5M | ||
| Q3 25 | $127.9M | $300.8M | ||
| Q2 25 | $111.7M | $235.1M | ||
| Q1 25 | $78.8M | $250.6M | ||
| Q4 24 | $100.9M | $196.5M | ||
| Q3 24 | $100.0M | $218.5M | ||
| Q2 24 | $90.5M | $140.4M | ||
| Q1 24 | $83.1M | $209.5M |
粗利率ATRCBOE
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 53.0% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 47.4% | ||
| Q3 24 | — | 50.4% | ||
| Q2 24 | — | 52.8% | ||
| Q1 24 | — | 52.5% |
営業利益率ATRCBOE
| Q4 25 | 11.0% | 33.5% | ||
| Q3 25 | 14.2% | 32.4% | ||
| Q2 25 | 14.9% | 28.9% | ||
| Q1 25 | 12.8% | 29.6% | ||
| Q4 24 | 14.2% | 27.0% | ||
| Q3 24 | 15.2% | 29.1% | ||
| Q2 24 | 13.8% | 21.6% | ||
| Q1 24 | 12.2% | 29.5% |
純利益率ATRCBOE
| Q4 25 | 7.7% | 26.0% | ||
| Q3 25 | 13.3% | 26.3% | ||
| Q2 25 | 11.6% | 20.0% | ||
| Q1 25 | 8.9% | 21.0% | ||
| Q4 24 | 11.9% | 17.7% | ||
| Q3 24 | 11.0% | 20.7% | ||
| Q2 24 | 9.9% | 14.4% | ||
| Q1 24 | 9.1% | 21.9% |
EPS（希薄化後）ATRCBOE
| Q4 25 | $1.13 | $2.97 | ||
| Q3 25 | $1.92 | $2.85 | ||
| Q2 25 | $1.67 | $2.23 | ||
| Q1 25 | $1.17 | $2.37 | ||
| Q4 24 | $1.48 | $1.85 | ||
| Q3 24 | $1.48 | $2.07 | ||
| Q2 24 | $1.34 | $1.33 | ||
| Q1 24 | $1.23 | $1.96 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $409.5M | $2.3B |
| 総負債低いほど良い | $1.1B | $1.4B |
| 株主資本純資産 | $2.7B | $5.1B |
| 総資産 | $5.3B | $9.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.43× | 0.28× |
8四半期トレンド — 暦四半期で整列
現金・短期投資ATRCBOE
| Q4 25 | $409.5M | $2.3B | ||
| Q3 25 | $264.8M | $1.5B | ||
| Q2 25 | $169.8M | $1.5B | ||
| Q1 25 | $136.8M | $1.2B | ||
| Q4 24 | $226.2M | $1.0B | ||
| Q3 24 | $327.9M | $763.2M | ||
| Q2 24 | $223.9M | $698.3M | ||
| Q1 24 | $201.1M | $595.1M |
総負債ATRCBOE
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $546.0M | $1.4B | ||
| Q2 25 | $535.1M | $1.4B | ||
| Q1 25 | $561.2M | $1.4B | ||
| Q4 24 | $688.1M | $1.4B | ||
| Q3 24 | $822.7M | $1.4B | ||
| Q2 24 | $681.5M | $1.4B | ||
| Q1 24 | $680.4M | $1.4B |
株主資本ATRCBOE
| Q4 25 | $2.7B | $5.1B | ||
| Q3 25 | $2.8B | $4.9B | ||
| Q2 25 | $2.7B | $4.7B | ||
| Q1 25 | $2.5B | $4.5B | ||
| Q4 24 | $2.5B | $4.3B | ||
| Q3 24 | $2.5B | $4.2B | ||
| Q2 24 | $2.4B | $4.0B | ||
| Q1 24 | $2.3B | $4.0B |
総資産ATRCBOE
| Q4 25 | $5.3B | $9.3B | ||
| Q3 25 | $5.1B | $9.1B | ||
| Q2 25 | $4.9B | $9.0B | ||
| Q1 25 | $4.5B | $8.7B | ||
| Q4 24 | $4.4B | $7.8B | ||
| Q3 24 | $4.6B | $8.7B | ||
| Q2 24 | $4.5B | $9.3B | ||
| Q1 24 | $4.4B | $8.2B |
負債/資本比率ATRCBOE
| Q4 25 | 0.43× | 0.28× | ||
| Q3 25 | 0.20× | 0.30× | ||
| Q2 25 | 0.20× | 0.31× | ||
| Q1 25 | 0.22× | 0.32× | ||
| Q4 24 | 0.28× | 0.34× | ||
| Q3 24 | 0.32× | 0.34× | ||
| Q2 24 | 0.28× | 0.36× | ||
| Q1 24 | 0.29× | 0.36× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $183.7M | $352.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $96.9M | $332.1M |
| FCFマージンFCF / 売上 | 10.1% | 27.6% |
| 設備投資強度設備投資 / 売上 | 9.0% | 1.7% |
| キャッシュ転換率営業CF / 純利益 | 2.47× | 1.12× |
| 直近12ヶ月FCF直近4四半期 | $299.6M | $1.7B |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローATRCBOE
| Q4 25 | $183.7M | $352.1M | ||
| Q3 25 | $177.6M | $153.9M | ||
| Q2 25 | $126.0M | $333.7M | ||
| Q1 25 | $82.7M | $912.9M | ||
| Q4 24 | $178.2M | $-710.4M | ||
| Q3 24 | $229.3M | $-578.5M | ||
| Q2 24 | $143.6M | $1.5B | ||
| Q1 24 | $92.3M | $895.6M |
フリーキャッシュフローATRCBOE
| Q4 25 | $96.9M | $332.1M | ||
| Q3 25 | $114.3M | $137.9M | ||
| Q2 25 | $62.5M | $313.4M | ||
| Q1 25 | $25.9M | $898.2M | ||
| Q4 24 | $112.2M | $-734.2M | ||
| Q3 24 | $162.7M | $-590.5M | ||
| Q2 24 | $75.4M | $1.5B | ||
| Q1 24 | $16.7M | $888.3M |
FCFマージンATRCBOE
| Q4 25 | 10.1% | 27.6% | ||
| Q3 25 | 11.9% | 12.1% | ||
| Q2 25 | 6.5% | 26.7% | ||
| Q1 25 | 2.9% | 75.2% | ||
| Q4 24 | 13.2% | -66.3% | ||
| Q3 24 | 17.9% | -55.9% | ||
| Q2 24 | 8.3% | 151.6% | ||
| Q1 24 | 1.8% | 92.8% |
設備投資強度ATRCBOE
| Q4 25 | 9.0% | 1.7% | ||
| Q3 25 | 6.6% | 1.4% | ||
| Q2 25 | 6.6% | 1.7% | ||
| Q1 25 | 6.4% | 1.2% | ||
| Q4 24 | 7.8% | 2.1% | ||
| Q3 24 | 7.3% | 1.1% | ||
| Q2 24 | 7.5% | 1.8% | ||
| Q1 24 | 8.3% | 0.8% |
キャッシュ転換率ATRCBOE
| Q4 25 | 2.47× | 1.12× | ||
| Q3 25 | 1.39× | 0.51× | ||
| Q2 25 | 1.13× | 1.42× | ||
| Q1 25 | 1.05× | 3.64× | ||
| Q4 24 | 1.77× | -3.62× | ||
| Q3 24 | 2.29× | -2.65× | ||
| Q2 24 | 1.59× | 10.64× | ||
| Q1 24 | 1.11× | 4.27× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
CBOE
| Liquidity Payments | $443.6M | 37% |
| Cash And Spot Markets | $431.3M | 36% |
| Transferred Over Time | $84.3M | 7% |
| Market Data Fees | $82.7M | 7% |
| Royalty Fees | $68.9M | 6% |
| Futures | $36.1M | 3% |
| Global FX | $24.4M | 2% |
| Other Revenue | $23.1M | 2% |
| Routing And Clearing | $20.1M | 2% |
